FDA Approves Brexanolone (Zulresso), First Drug for Postpartum Depression

Share this post

The drug can be given only in a certified facility, and women will have to stay for the entire 2.5 days it takes for the infusion.
FDA Approvals

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply